GlassScriptPhysician profile
Cara L Harris
NPI 1407280183
$2,001.88
in general payments reported to CMS, 2019-2025
21 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $540 · 2022: $418 · 2023: $460 · 2024: $115 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,044.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $344.25 | 2021-2025 | Airsupra, Andexxa, Farxiga |
| Abbvie INC. | $257.93 | 2021-2024 | |
| Abbott Laboratories | $202.43 | 2022-2025 | Proclaim, Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.86 | 2021-2023 | Jardiance |
| Biohaven Pharmaceuticals, INC. | $165.64 | 2021 | |
| Novo Nordisk INC | $164.74 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $121.82 | 2023 | Tazverik |
| Lilly USA, LLC | $73.48 | 2021-2024 | Mounjaro |
| Pfizer INC. | $73.27 | 2023-2025 | |
| Boston Scientific Corporation | $71.03 | 2023-2024 | |
| Medtronic, INC. | $48.18 | 2022-2025 | Interstim |
| Exact Sciences Corporation | $47.00 | 2025 | Cologuard Collection Kit |
| Cranial Technologies, INC | $43.85 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.45 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $41.21 | 2025 | Caplyta |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $27.64 | 2022 | |
| Glaxosmithkline, LLC. | $25.51 | 2023 | Trelegy Ellipta |
| Gilead Sciences, INC. | $18.62 | 2021 | |
| Ironshore Pharmaceuticals INC. | $16.88 | 2023 | Jornay Pm |
| Biohaven Pharmaceutical Holding Company LTD. | $15.91 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.